AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Benzocaine is effective in providing temporary relief from pain and discomfort associated with various conditions. It numbs the nerves in the affected area, reducing the sensation of pain.
Sore Throat Relief: Benzocaine-containing products such as throat sprays, lozenges, and oral gels are often used to alleviate sore throat pain and irritation. They provide a numbing effect on the throat, reducing the urge to cough and soothing discomfort.
Teething Pain Relief: Benzocaine is used in some teething gels and medications to alleviate the discomfort associated with teething in infants and young children. It temporarily numbs the gums, providing relief from pain and irritation.
Mouth Sores: Benzocaine-containing oral gels and creams are commonly used to relieve pain caused by mouth sores, including canker sores, cold sores, and gum irritation. It helps reduce pain and discomfort, allowing the sores to heal more comfortably.
Minor Skin Irritations: Benzocaine can be found in some topical creams and ointments used to relieve minor skin irritations, including itching, burning, and insect bites. It provides temporary relief by numbing the affected area.
Topical Anesthetic: Benzocaine is widely used as a topical anesthetic in various medical procedures, including minor surgical procedures, skin biopsies, and catheter insertions. It helps numb the skin and reduce pain during these procedures.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Lacticaseibacillus paracasei | Reduces |
| species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| 📓 Direct Citations | 👪👶 Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Parabacteroides | genus | Decreases |
| 0 | 1 | Streptococcus | genus | Decreases |
| 0 | 1 | Lacticaseibacillus | genus | Decreases |
| 1 | 0 | Streptococcus salivarius | species | Decreases |
| 1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
| 1 | 0 | Parabacteroides distasonis | species | Decreases |
| 0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
| 0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 0.7 | 0.7 | |
| Age-Related Macular Degeneration and Glaucoma | 0.4 | -0.4 | |
| Allergic Rhinitis (Hay Fever) | 0.7 | 0.3 | 1.33 |
| Allergies | 0.4 | 0.4 | |
| Allergy to milk products | 0.4 | -0.4 | |
| Alopecia (Hair Loss) | 0.1 | 0.1 | |
| Alzheimer's disease | 0.4 | 0.3 | 0.33 |
| Ankylosing spondylitis | 0.4 | 0.4 | |
| Anorexia Nervosa | 0.7 | 0.3 | 1.33 |
| Antiphospholipid syndrome (APS) | 0.3 | 0.3 | |
| Asthma | 0.5 | 0.3 | 0.67 |
| Atrial fibrillation | 0.7 | 0.4 | 0.75 |
| Autism | 0.7 | 0.8 | -0.14 |
| Autoimmune Disease | 0.3 | 0.3 | |
| Barrett esophagus cancer | 0.3 | -0.3 | |
| Biofilm | 0.3 | 0.3 | |
| Bipolar Disorder | 0.4 | 0.4 | |
| Brain Trauma | 0.3 | 0.3 | |
| Cancer (General) | 0.2 | -0.2 | |
| Carcinoma | 0.7 | 0.4 | 0.75 |
| Celiac Disease | 0.3 | 0.4 | -0.33 |
| Cerebral Palsy | 0.3 | 0.3 | |
| Chronic Fatigue Syndrome | 0.3 | 0.4 | -0.33 |
| Chronic Kidney Disease | 0.4 | 0.4 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.5 | 0.3 | 0.67 |
| Chronic Urticaria (Hives) | 0.3 | 0.3 | |
| Coagulation / Micro clot triggering bacteria | 0.7 | 0.3 | 1.33 |
| Cognitive Function | 0.7 | 0.3 | 1.33 |
| Colorectal Cancer | 0.9 | 0.9 | |
| Coronary artery disease | 0.3 | 0.3 | |
| COVID-19 | 0.7 | 0.5 | 0.4 |
| Crohn's Disease | 0.8 | 0.4 | 1 |
| deep vein thrombosis | 0.3 | -0.3 | |
| Denture Wearers Oral Shifts | 0.5 | 0.5 | |
| Depression | 1 | 0.9 | 0.11 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 0.3 | 0.5 | -0.67 |
| Endometriosis | 0.7 | 0.7 | |
| Eosinophilic Esophagitis | 0.3 | -0.3 | |
| Epilepsy | 0.3 | 0.4 | -0.33 |
| Fibromyalgia | 0.4 | 0.4 | |
| Functional constipation / chronic idiopathic constipation | 0.7 | 0.4 | 0.75 |
| gallstone disease (gsd) | 0.4 | 0.4 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | -0.3 | |
| Generalized anxiety disorder | 0.3 | 0.3 | 0 |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 0.3 | 0.3 | |
| Graves' disease | 0.4 | 0.3 | 0.33 |
| Gulf War Syndrome | 0.3 | 0.3 | |
| Halitosis | 0.3 | 0.3 | 0 |
| Heart Failure | 0.7 | 0.7 | |
| hemorrhagic stroke | 0.4 | 0.4 | |
| Hidradenitis Suppurativa | 0.3 | 0.3 | |
| hyperglycemia | 0.2 | 0.4 | -1 |
| hypertension (High Blood Pressure | 0.7 | 0.3 | 1.33 |
| Hypoxia | 0.4 | 0.4 | |
| IgA nephropathy (IgAN) | 0.7 | 0.7 | |
| Inflammatory Bowel Disease | 0.9 | 0.4 | 1.25 |
| Insomnia | 0.5 | 0.3 | 0.67 |
| Intracranial aneurysms | 0.4 | 0.4 | |
| Irritable Bowel Syndrome | 0.3 | 0.7 | -1.33 |
| ischemic stroke | 0.7 | 0.7 | |
| Liver Cirrhosis | 0.9 | 0.3 | 2 |
| Long COVID | 0.7 | 0.4 | 0.75 |
| Mast Cell Issues / mastitis | 0.3 | 0.3 | |
| ME/CFS with IBS | 0.3 | 0.3 | |
| ME/CFS without IBS | 0.3 | 0.1 | 2 |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.3 | 0.3 | |
| Metabolic Syndrome | 0.7 | 0.7 | 0 |
| Mood Disorders | 1 | 0.9 | 0.11 |
| multiple chemical sensitivity [MCS] | 0.5 | 0.5 | |
| Multiple Sclerosis | 0.9 | 0.8 | 0.13 |
| myasthenia gravis | 0.3 | 0.3 | |
| neuropathic pain | 0.4 | -0.4 | |
| Neuropathy (all types) | 0.3 | 0.4 | -0.33 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 0.3 | |
| Obesity | 0.7 | 1.1 | -0.57 |
| obsessive-compulsive disorder | 0.7 | 0.3 | 1.33 |
| Osteoarthritis | 0.3 | 0.3 | 0 |
| Osteoporosis | 0.3 | -0.3 | |
| pancreatic cancer | 0.3 | 0.3 | 0 |
| Parkinson's Disease | 0.9 | 0.3 | 2 |
| Polycystic ovary syndrome | 0.8 | 0.3 | 1.67 |
| Premenstrual dysphoric disorder | 0.4 | -0.4 | |
| primary biliary cholangitis | 0.3 | 0.3 | 0 |
| Primary sclerosing cholangitis | 0.7 | 0.5 | 0.4 |
| Psoriasis | 0.3 | 0.5 | -0.67 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.7 | 0.7 | |
| Schizophrenia | 0.7 | 0.4 | 0.75 |
| Sjögren syndrome | 0.7 | 0.4 | 0.75 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.3 | |
| Stress / posttraumatic stress disorder | 0.4 | 0.4 | 0 |
| Systemic Lupus Erythematosus | 0.7 | 0.7 | |
| Tic Disorder | 0.3 | 0.3 | |
| Tourette syndrome | 0.3 | 0.3 | |
| Type 1 Diabetes | 0.3 | 0.3 | 0 |
| Type 2 Diabetes | 0.7 | 0.7 | 0 |
| Ulcerative colitis | 0.7 | 0.4 | 0.75 |
| Unhealthy Ageing | 0.3 | 0.4 | -0.33 |
| Vitiligo | 0.7 | 0.4 | 0.75 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
